Eli Lilly & Co. (LLY)
1001.20
+18.98
(+1.93%)
USD |
NYSE |
Dec 10, 14:05
Eli Lilly Market Cap: 896.09B for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 170.21B |
| Regeneron Pharmaceuticals, Inc. | 75.38B |
| Adverum Biotechnologies, Inc. | 96.26M |
| Viking Therapeutics, Inc. | 4.134B |
| Moderna, Inc. | 11.24B |
Market Cap Related Metrics
| PE Ratio | 49.52 |
| PS Ratio | 15.36 |
| PEG Ratio | 0.4086 |
| Price to Book Value | 37.66 |
| Price to Free Cash Flow | 141.82 |
| Price | 1001.20 |
| Earnings Yield | 2.02% |
| PEGY Ratio | 0.4065 |
| Operating PE Ratio | 34.59 |
| Normalized PE Ratio | 44.34 |